PLRZ · Polyrizon Ltd.
Market Cap
$22.22M
Shares
2.43M
Volume · Oct 21
7019
Avg daily vol (3M)
60.95K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.20
Open$9.24
Day$9.20–9.29
52W close$3.13–17.17
Avg vol 30d31K
Short int51K · 2.1% float · 1.8d
Short vol17%
DataOct 2024–Oct 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$4.58M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-19.9%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+34,021.4%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
2.1%
Latest settlement · 1.8 days to cover
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 16.7 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−28%
below
Price vs 50-day avg
−14%
below
RSI (14)
41
neutral
MACD trend
Positive
52-week position
43%
mid-range
Momentum
relative strength
1-month return
−18%
trailing
6-month return
−42%
trailing
YTD return
+8%
this year
Relative strength
−50%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $11 › 200d $13 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.09% of float · ▼ -8.5% MoM · 1.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 1-yr range
Squeeze score
38
low risk · 0–100
Fundamentals
EPS growth
−99%
Y/Y
Free cash flow
$-4.5M
Quant / Vol
risk profile
Volatility
204%
annualized · 1-yr
Max drawdown
−54%
past year
ATR
10.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−28%
Bearish
Price vs 50-day avg
−14%
Bearish
RSI (14)
41
Neutral
MACD trend
Positive
Bullish
52-week position
43%
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $11 › 200d $13 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.09% of float · ▼ -8.5% MoM · 1.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $3
Now $9 · 43%
Range high $17
vs 200-day avg -28%
vs 50-day avg -14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PLRZ
this stock
Polyrizon Ltd.
|
$22.22M | +8.4% | — | — | 2.1% |
|
VRTX
Vertex Pharmaceuticals Inc
|
$131.39B | +15.7% | +46.2% | 30.2 | 1.8% |
|
MRNA
Moderna, Inc.
|
$96.65B | +733.5% | +4.3% | — | 7.7% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.13B | +4.4% | +20.8% | 20.0 | 2.1% |
|
CSLLY
Csl Ltd
|
$66.22B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
4
- % held
- 9.1%
- Net QoQ
- +185.0K sh
- Top holder
- MMCAP International Inc.…
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PLRZ | -11.6% | -17.6% | -42.1% | -14.7% | +8.4% |
| SPY | +0.5% | +0.7% | +7.6% | +1.4% | +13.4% |
| vs SPY | -12.1% | -18.3% | -49.7% | -16.1% | -5.0% |